Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950157-09-000323
Filing Date
2009-05-29
Accepted
2009-05-29 15:33:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 128783
2 AGREEMENT AND PLAN OF MERGER ex1.htm EX-1 716206
3 HORIZON TENDER & SUPPORT AGREEMENT ex2.htm EX-2 151438
4 BELLDEGRUN TENDER & SUPPORT AGREEMENT ex3.htm EX-3 139699
5 AUERBACH TENDER & SUPPORT AGREEMENT ex4.htm EX-35 131218
  Complete submission text file 0000950157-09-000323.txt   1269380
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024
Business Address 10990 WILSHIRE BLVD. SUITE 1200 LOS ANGELES CA 90024 310 943 8040
Cougar Biotechnology, Inc. (Subject) CIK: 0001335102 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81112 | Film No.: 09861401
SIC: 2834 Pharmaceutical Preparations